RAC 2.73% $1.61 race oncology ltd

Ann: Race Strategic Update August 2023, page-590

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 929 Posts.
    lightbulb Created with Sketch. 1097
    Thanks II for the good reminder for everyone !

    Kyprolis current annual sale world wide sales $USD1.378 bill, and increasing YoY ...

    https://hotcopper.com.au/data/attachments/5742/5742486-5e49635536e98758fb255a71a2e302f1.jpg

    accounting for 5 % of Amagen's total product sales

    https://hotcopper.com.au/data/attachments/5742/5742499-6d388a80198d03301ace360b90eb4921.jpg

    for those new investors not familair with Race's discovery of cardio protection, here
    https://raceoncology.com/expanded-heart-protection-discovery-for-zantrene/

    https://hotcopper.com.au/data/attachments/5742/5742505-543f8eedd92c133048951eae81d4a863.jpg

    Then go re-read the Triangle report to understand its conclusions of the value of bisantrene are not so fancical !

    https://raceoncology.com/april-2023-update/

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.